These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2048298)

  • 1. [The potential of using low-frequency ultrasound for the correction of immunodeficiency states].
    Sologub EN; Siziakina LP; Moskalenko EP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (1):44-6. PubMed ID: 2048298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunocorrecting properties of low-frequency ultrasound].
    Sologub EN; Siziakina LP
    Fiziol Zh (1978); 1990; 36(1):84-7. PubMed ID: 2323451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial reconstitution of TNP-Ficoll responses and IgG3 expression in Xid mice undergoing graft-vs-host reaction.
    Golding H; Foiles PG; Rittenberg MB
    J Immunol; 1982 Dec; 129(6):2641-6. PubMed ID: 6982935
    [No Abstract]   [Full Text] [Related]  

  • 4. B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid).
    Reid GK; Osmond DG
    J Immunol; 1985 Oct; 135(4):2299-302. PubMed ID: 3875649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of responsiveness in lymphocytes of immunodeficient patients' cells implanted with foreign plasma membranes.
    Levy D; Porat Y; Pick I; Handzel ZT; Schlesinger M; Tanay A; Zan-Bar I
    Immunodeficiency; 1993; 4(1-4):43-6. PubMed ID: 8167731
    [No Abstract]   [Full Text] [Related]  

  • 6. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
    Kondrat'eva TK; Mikheeva NV; Fontalin LN
    Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice.
    Chow DA; Bennet RD
    J Immunol; 1989 May; 142(10):3702-6. PubMed ID: 2785560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myelopeptide correction of the differentiation of hematopoietic precursor cells in mice with experimental T-immunodeficiency].
    Rudneva TB; Osipova EIu; Makhaĭlova AA; Man'ko VM
    Biull Eksp Biol Med; 1989 Jun; 107(6):718-20. PubMed ID: 2790172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for defects in accessory and T cell subsets in mice expressing the xid defect.
    Clayberger C; DeKruyff RH; Fay R; Huber B; Cantor H
    J Mol Cell Immunol; 1985; 2(2):61-9. PubMed ID: 3916931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of congenitally immunologic mutant New Zealand mice. VI. Spontaneous and induced autoantibodies to red cells and DNA occur in New Zealand X-linked immunodeficient (Xid) mice without phenotypic alternations of the Xid gene or generalized polyclonal B cell activation.
    Ohsugi Y; Gershwin ME; Ahmed A; Skelly RR; Milich DR
    J Immunol; 1982 May; 128(5):2220-7. PubMed ID: 6977588
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular defects in T- and B-cell primary immunodeficiency diseases.
    Cunningham-Rundles C; Ponda PP
    Nat Rev Immunol; 2005 Nov; 5(11):880-92. PubMed ID: 16261175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
    Scher I; Berning AK; Kessler S; Finkelman FD
    J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymus transplantation.
    Hong R
    Birth Defects Orig Artic Ser; 1983; 19(3):259-65. PubMed ID: 6360237
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of B- and T-cell function in immunodeficiency.
    Eskola J; Ruuskanen O
    Ann Clin Res; 1987; 19(4):258-62. PubMed ID: 3314651
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer.
    Broder S; Muul L; Megson M; Waldmann TA
    Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of the xid gene in X chromosome congenic mice. I. Inability of C3.CBA/N mice to respond to thymus-dependent antigens in adoptive transfer assays.
    Kenny JJ; Guelde G; Hansen C; Mond JJ
    J Immunol; 1987 Mar; 138(5):1363-71. PubMed ID: 2949014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spleen and antibody formation].
    Bürki H; Luscieti P; Pedrinis E; Schädeli J; Hess MW; Cottier H
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1351-60. PubMed ID: 4607935
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of immunologic mutations as probes of cellular interactions and autoimmunity in New Zealand mice.
    Bray KR; Gershwin ME
    Exp Cell Biol; 1984; 52(1-2):85-96. PubMed ID: 6141962
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.